Skip to main content
BNTX
NASDAQ Life Sciences

CEO-Associated Entity Files Intent to Sell $80M in BioNTech Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$94
Mkt Cap
$23.604B
52W Low
$79.52
52W High
$124
52W Position info
18% above low
Off High info
24% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

BNTX sits 18% above its 52-week low of $79.52 on light trading volume (0.3× avg).

Summary

An entity associated with BioNTech's CEO and a 10% stockholder has filed to sell over $80 million worth of shares, marking a significant insider disposition.


Key Events · Ownership and Investor Activity · BNTX

  • Intent to Sell Significant Stake

    Medine GmbH, an entity associated with CEO Ugur Sahin and listed as an officer and 10% stockholder, plans to sell 858,209 shares.

  • Substantial Market Value

    The proposed sale has an approximate market value of $80.4 million.

  • Follows Previous Insider Sales

    This is the second Form 144 filing by Medine GmbH in the last three months, indicating a pattern of insider sales.

  • CEO Association

    The selling entity is associated with CEO Ugur Sahin, making this a notable insider transaction.


Analysis · BNTX · Life Sciences

Medine GmbH, an entity associated with CEO Ugur Sahin and identified as an officer and 10% stockholder, has filed a Form 144 indicating intent to sell a substantial block of shares. This follows a previous Form 144 filing by the same entity in February and comes after recent news of co-founders departing to establish a new company. The proposed sale of over $80 million worth of shares represents a significant reduction in exposure by a key insider.

How filings like this one have moved

In the 30 days to Oct 16, 2026, 36.6% of the 978 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BNTX was trading at $94.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23.6B. The 52-week trading range was $79.52 to $124.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BNTX - Latest Insights

BNTX
Oct 13, 2026, 11:25 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $91.04
Real-time Price: $90.69 info
Change: -$0.350 (-0.38%) info
Market Cap: $22.659B info
BNTX
Oct 13, 2026, 6:45 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $91.84
Real-time Price: $90.69 info
Change: -$1.15 (-1%) info
Market Cap: $22.659B info
BNTX
Sep 28, 2026, 9:04 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $97.26
Real-time Price: $90.69 info
Change: -$6.57 (-7%) info
Market Cap: $22.659B info
BNTX
Sep 14, 2026, 8:28 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $102.77
Real-time Price: $90.69 info
Change: -$12.08 (-12%) info
Market Cap: $22.659B info
BNTX
Sep 14, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $99.15
Real-time Price: $90.69 info
Change: -$8.46 (-9%) info
Market Cap: $22.659B info